PRRG4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.403400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.811200E-01
Normal-vs-Stage2
4.072600E-01
Normal-vs-Stage3
8.429200E-01
Normal-vs-Stage4
2.887200E-01
Stage1-vs-Stage2
9.434400E-01
Stage1-vs-Stage3
3.095400E-01
Stage1-vs-Stage4
7.485000E-01
Stage2-vs-Stage3
2.420400E-01
Stage2-vs-Stage4
7.753600E-01
Stage3-vs-Stage4
1.466240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.557200E-01
Normal-vs-AfricanAmerican
6.403200E-01
Normal-vs-Asian
4.508800E-01
Caucasian-vs-AfricanAmerican
6.366800E-01
Caucasian-vs-Asian
8.921800E-01
AfricanAmerican-vs-Asian
6.875000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.882400E-01
Normal-vs-Female
5.389800E-01
Male-vs-Female
4.632300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.873000E-01
Normal-vs-Age(41-60Yrs)
3.320800E-01
Normal-vs-Age(61-80Yrs)
5.074000E-01
Normal-vs-Age(81-100Yrs)
6.717800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.558600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.564600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.825400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.893600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.809440E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.810600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.765400E-01
Normal-vs-Daily Drinker
5.277400E-01
Normal-vs-Weekly Drinker
7.912200E-01
Normal-vs-Occasional Drinker
2.644800E-01
Normal-vs-Social Drinker
2.903600E-01
Non Drinker-vs-Daily Drinker
9.164600E-01
Non Drinker-vs-Weekly Drinker
5.508200E-01
Non Drinker-vs-Occasional Drinker
3.040600E-01
Non Drinker-vs-Social Drinker
9.316200E-01
Daily Drinker-vs-Weekly Drinker
5.626000E-01
Daily Drinker-vs-Occasional Drinker
4.353600E-01
Daily Drinker-vs-Social Drinker
8.580000E-01
Weekly Drinker-vs-Occasional Drinker
2.115000E-01
Weekly Drinker-vs-Social Drinker
6.074200E-01
Occasional Drinker-vs-Social Drinker
2.432200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.61189975098364E-10
Normal-vs-Grade 2
<1E-12
Normal-vs-Grade 3
1.62447832963153E-12
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.144700E-03
Grade 1-vs-Grade 3
8.777300E-04
Grade 1-vs-Grade 4
4.61189975098364E-10
Grade 2-vs-Grade 3
5.967200E-01
Grade 2-vs-Grade 4
<1E-12
Grade 3-vs-Grade 4
1.62447832963153E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.577200E-01
Normal-vs-NonDiabetic
4.434200E-01
Diabetic-vs-NonDiabetic
4.474400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.660000E-01
Normal-vs-NoPancreatitis
4.920200E-01
Pancreatitis-vs-NoPancreatitis
6.261200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.723800E-01
Normal-vs-N1
4.085400E-01
N0-vs-N1
1.117010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.056400E-01
Normal-vs-TP53-NonMutant
4.077200E-01
TP53-Mutant-vs-TP53-NonMutant
2.486400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
